dc.contributor.author | Kissler, Stephane | |
dc.contributor.author | Ventura, Andrea | |
dc.coverage.temporal | Fall 2004 | |
dc.date.accessioned | 2023-03-06T16:51:26Z | |
dc.date.available | 2023-03-06T16:51:26Z | |
dc.date.issued | 2004-12 | |
dc.identifier | 7.344-Fall2004 | |
dc.identifier.other | 7.344 | |
dc.identifier.other | IMSCP-MD5-dccdca513c44a30be6e97bbaf0f2733e | |
dc.identifier.uri | https://hdl.handle.net/1721.1/148326 | |
dc.description.abstract | This course is one of many Advanced Undergraduate Seminars offered by the Biology Department at MIT. These seminars are tailored for students with an interest in using primary research literature to discuss and learn about current biological research in a highly interactive setting. To understand and treat any disease with a genetic basis or predisposition, scientists and clinicians need effective ways of manipulating the levels of genes and gene products. Conventional methods for the genetic modification of many experimental organisms are technically demanding and time consuming. Just over 5 years ago, a new mechanism of gene-silencing, termed RNA interference (RNAi), was discovered. In addition to being a fascinating biological process, RNAi provides a revolutionary technology that has already changed the way biomedical research is done and that may even prove useful for genetic interventions in a clinical context. In this course, students learn how RNAi was discovered, how it works, and what its physiological relevance might be. How RNAi can be harnessed to modulate gene expression and perform genetic screens, both in cells and in various organisms is also covered. Finally, this course examines the first attempts to use RNAi for the treatment of models of human diseases in experimental animals. | en |
dc.language.iso | en-US | |
dc.rights | This site (c) Massachusetts Institute of Technology 2023. Content within individual courses is (c) by the individual authors unless otherwise noted. The Massachusetts Institute of Technology is providing this Work (as defined below) under the terms of this Creative Commons public license ("CCPL" or "license") unless otherwise noted. The Work is protected by copyright and/or other applicable law. Any use of the work other than as authorized under this license is prohibited. By exercising any of the rights to the Work provided here, You (as defined below) accept and agree to be bound by the terms of this license. The Licensor, the Massachusetts Institute of Technology, grants You the rights contained here in consideration of Your acceptance of such terms and conditions. | en |
dc.rights | Attribution-NonCommercial-ShareAlike 3.0 Unported | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/3.0/ | * |
dc.subject | RNA interference | en |
dc.subject | RNAi | en |
dc.subject | RNA | en |
dc.subject | genetic analysis | en |
dc.subject | gene therapy | en |
dc.subject | gene products | en |
dc.subject | gene silencing | en |
dc.subject | gene expression | en |
dc.subject | human disease models | en |
dc.subject | mRNA | en |
dc.subject | genetic interference | en |
dc.subject | short interfering RNA | en |
dc.subject | siRNAs | en |
dc.subject | expression vectors | en |
dc.subject | RNA sequences | en |
dc.subject | nucleotide fragments | en |
dc.subject | microRNA | en |
dc.subject | mRNA degradation | en |
dc.subject | transgenic mice | en |
dc.subject | lentivirus | en |
dc.subject | knock-down animals | en |
dc.subject | tissue specificity | en |
dc.title | 7.344 RNA Interference: A New Tool for Genetic Analysis and Therapeutics, Fall 2004 | en |
dc.title.alternative | RNA Interference: A New Tool for Genetic Analysis and Therapeutics | en |
dc.type | Learning Object | |
dc.contributor.department | Massachusetts Institute of Technology. Department of Biology | |
dc.audience.educationlevel | Undergraduate | |
dc.subject.cip | 260806 | en |
dc.subject.cip | Human/Medical Genetics | en |
dc.date.updated | 2023-03-06T16:51:32Z | |